SHAPING THE FUTURE OF IMMUNOTHERAPY

ABOUT US

THIS IS SHAPE

Shape Biopharmaceuticals is a next-generation immunotherapy developer. With our ambitious team and network, we strive to create a new class of immunotherapeutic drugs for chronic human diseases with high unmet treatment needs, leveraging computational epitope-specific antigen design and next-generation nanoparticle engineering.

OUR FOCUS

WHAT WE DO

Optimizing Immunotherapy Design and Delivery

antigen-engineering

Antigen Engineering Technology

We employ leading-edge computational drug design and protein engineering technologies to optimize the immunological and antigenic properties of our target antigens.

vaccine-formulation-optimization

Nano Formulation

We optimize the formulation using tailored nanoparticle-based delivery systems and specific immunomodulators to ensure optimal therapeutic responses in diverse patient populations.

ENABLING SMARTER IMMUNOTHERAPIES FOR PATIENTS

We are pioneering a new class of structurally defined, 3D optimized, engineered nanomedicines that leverage the immune system to generate personalized therapeutic antibodies directly in patients.

To learn more about our current programs, please contact us here → 

Registered Office in the U.S.:

Registered Office in Switzerland:

© Shape Biopharmaceuticals Inc. 2024